GSK Research and Charts

GSK - GlaxoSmithKline PLC ADR (Healthcare: Drug Manufacturers - General)

Projected Earnings Date: 2025-10-29 (Delayed quote data 2025-09-12)

Last 40.85	Change ⇓ -0.64 (-1.54%)	Volume 4,741,955
	Open 41.20	High 41.39	Low 40.50

8EMA (Daily) 40.52	40EMA (Daily) 39.37	50EMA (Daily) 39.22	STO (Daily) 82.793	MACD Hist (Daily) 0.239
8EMA (Weekly) 39.613	40EMA (Weekly) 38.38	50EMA (Weekly) 38.32	STO (Weekly) 64.903	MACD Hist (Weekly) 0.508


Company Profile
In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.